On September 26, 2023, Forte Biosciences Inc announced that it held its 2023 annual meeting of shareholders on September 19, 2023 and declared the voting results. Accordingly, a proposal submitted by ATG Capital Management LLC requesting the Company to amend the amended and restated bylaws was not approved by the shareholders of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.745 USD | +2.41% | +4.33% | -9.33% |
03-18 | Forte Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
01-05 | Camac Partners Provides Information to Shareholders | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.33% | 27.11M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- FBRX Stock
- News Forte Biosciences, Inc.
- Declaration of Voting Results by Forte Biosciences